Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma.
Target Oncol
; 15(6): 773-785, 2020 12.
Article
in En
| MEDLINE
| ID: mdl-33044683
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
Main subject:
Carcinoma, Hepatocellular
/
Eosinophils
/
Sorafenib
/
Liver Neoplasms
Type of study:
Clinical_trials
/
Prognostic_studies
Language:
En
Journal:
Target Oncol
Year:
2020
Type:
Article
Affiliation country:
Italy